| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |